Medication Adherence Intervention in Chronic Recurrent Multifocal Osteomyelitis (CRMO)

Assessing Medication Adherence in Patients With Chronic Recurrent Multifocal Osteomyelitis

NCT06232603•Seattle Children's Hospital

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Chronic Recurrent Multifocal Osteomyelitis

Interventions

Education of medication management

Locations

United States

Locations (1)

Seattle Children's Hospital

Seattle, Washington, United States

Key Dates

Start Date

February 20, 2024

Primary Completion Date

June 18, 2024

Completion Date

June 18, 2024

Last Updated

July 29, 2024

Sponsors

Lead Sponsor

Seattle Children's Hospital

Collaborators

University of Washington

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 29, 2024Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions